Company: SPEG
Filing Date: 2025-06-20
Form Type: S-1/A
Source: 0001213900-25-055713
Chunk: 5

Company: Silver Pegasus Acquisition Corp.
Filing Date: 2025-06-20
Form: S-1/A
Chunk 5
---
 may also incentivize non -managingsponsor investors to vote their public shares, if any, in favor of a business combination even if the combined company may decline in value and be unprofitable for public shareholders after the business combination. The following chart sets forth further examples of how the Class B.2 private placement warrants could be exchanged for shares of common stock under different stock price scenarios:

| Share Price Post                                   
 De-SPAC                                            |     | $ |  10.00 |     | $ |   8.50 |     | $ |   7.00 |     | $ |    5.50 |     | $ |    4.80 |     | $ |    4.00 |     | $ |    2.50 |     | $ |    1.00 |
| Number of shares                                   
 of Common Stock Issuable per B.2 Warrant           |     |   |     17 |     |   |     14 |     |   |     12 |     |   |       9 |     |   |       8 |     |   |       7 |     |   |       4 |     |   |       2 |
| Maximum number of shares issuable for B.2 Warrants |     |   | 60,000 |     |   | 70,588 |     |   | 85,714 |     |   | 109,091 |     |   | 125,000 |     |   | 150,000 |     |   | 240,000 |     |   | 600,000 |

Please see “Description of Securities — Class B.2 Private Placement Warrants”. None of the non -managingsponsor members have expressed an interest in purchasing units in the public offering. However, whether or not the non -managingsponsor members purchase any units in this offering or in the open market after the offering, the non -managingsponsor members will have different interests than our other public shareholders in approving our initial business combination and otherwise exercising their rights as public shareholders because of their indirect ownership of founder shares and private placement warrants as further discussed in this prospectus. Of the 3,250,000 private placement warrants, the sponsor has agreed to purchase 2,000,000 private placement warrants at the time of the business combination (whether or not the underwriters’ over -allotmentoption is exercised), retaining an economic interest